Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 2
2009 5
2010 5
2011 9
2012 5
2013 7
2014 8
2015 8
2016 13
2017 11
2018 7
2019 10
2020 10
2021 5
2022 8
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
Advances in covalent kinase inhibitors.
Abdeldayem A , Raouf YS , Constantinescu SN , Moriggl R , Gunning PT . Abdeldayem A , et al. Among authors: gunning pt. Chem Soc Rev. 2020 May 7;49(9):2617-2687. doi: 10.1039/c9cs00720b. Epub 2020 Mar 30. Chem Soc Rev. 2020. PMID: 32227030 Review.
Targeting STAT3 and STAT5 in Cancer.
de Araujo ED, Keserű GM, Gunning PT, Moriggl R. de Araujo ED, et al. Among authors: gunning pt. Cancers (Basel). 2020 Jul 22;12(8):2002. doi: 10.3390/cancers12082002. Cancers (Basel). 2020. PMID: 32707820 Free PMC article.
JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
Erdogan F, Radu TB, Orlova A, Qadree AK, de Araujo ED, Israelian J, Valent P, Mustjoki SM, Herling M, Moriggl R, Gunning PT. Erdogan F, et al. Among authors: gunning pt. J Cell Mol Med. 2022 Apr;26(7):2049-2062. doi: 10.1111/jcmm.17228. Epub 2022 Mar 1. J Cell Mol Med. 2022. PMID: 35229974 Free PMC article. Review.
Targeting prenylation inhibition through the mevalonate pathway.
Manaswiyoungkul P, de Araujo ED, Gunning PT. Manaswiyoungkul P, et al. Among authors: gunning pt. RSC Med Chem. 2019 Dec 23;11(1):51-71. doi: 10.1039/c9md00442d. eCollection 2020 Jan 1. RSC Med Chem. 2019. PMID: 33479604 Free PMC article. Review.
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED, Orlova A, Neubauer HA, Bajusz D, Seo HS, Dhe-Paganon S, Keserű GM, Moriggl R, Gunning PT. de Araujo ED, et al. Among authors: gunning pt. Cancers (Basel). 2019 Nov 8;11(11):1757. doi: 10.3390/cancers11111757. Cancers (Basel). 2019. PMID: 31717342 Free PMC article. Review.
Direct Targeting Options for STAT3 and STAT5 in Cancer.
Orlova A, Wagner C, de Araujo ED, Bajusz D, Neubauer HA, Herling M, Gunning PT, Keserű GM, Moriggl R. Orlova A, et al. Among authors: gunning pt. Cancers (Basel). 2019 Dec 3;11(12):1930. doi: 10.3390/cancers11121930. Cancers (Basel). 2019. PMID: 31817042 Free PMC article. Review.
Progress towards the development of SH2 domain inhibitors.
Kraskouskaya D, Duodu E, Arpin CC, Gunning PT. Kraskouskaya D, et al. Among authors: gunning pt. Chem Soc Rev. 2013 Apr 21;42(8):3337-70. doi: 10.1039/c3cs35449k. Epub 2013 Feb 11. Chem Soc Rev. 2013. PMID: 23396540 Review.
100 results